Achieving Optimal Medical Therapy Through Percutaneous Treatment of Secondary Mitral Regurgitation to Improve Outcome in Patients With HFrEF
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 520 participants.
Also called NCT07758023
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 520 participants
- Registry
-
NCT07758023
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Recruiting
Technical summary
Registry record NCT07758023. Randomized; no masking; primary purpose treatment. Start 2026-10-15 (actual); primary completion 2030-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Achieving Optimal Medical Therapy Through Percutaneous Treatment of Secondary Mitral Regurgitation to Improve Outcome in Patients With HFrEF
- Acronym
- ACHILLES-HF
- Condition
- Mitral Regurgitation Functional
- Intervention (Device)
- M-TEER
- Intervention (Other)
- Standardized GDMT Up-Titration
- Lead sponsor
- University Medical Center Mainz
- Collaborator
- Abbott
Record details
- Record id
cardio:ct-nct07758023- Content hash
c42748ae93c9118b8399fa903e355ca33608821878c1c5c69aa8bbcf49901445